[Phosphatidylcholine in the control of arteriosclerosis].
D000284:Administration, Oral; D000818:Animals; D001158:Arteries / Q000378:metabolism; D001161:Arteriosclerosis / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D002462:Cell Membrane / Q000378:metabolism; D002784:Cholesterol / Q000097:blood / Q000378:metabolism; D004032:Diet; D005231:Fatty Acids, Unsaturated / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007263:Infusions, Parenteral; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000008:administration & dosage / Q000627:therapeutic use*; D010743:Phospholipids / Q000097:blood / Q000378:metabolism; D011817:Rabbits
D005231:Fatty Acids, Unsaturated; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D010713:Phosphatidylcholines; D010743:Phospholipids; D002784:Cholesterol
La fosfatidilcolina nel controllo dell'arteriosclerosi.